CONFIDENTIAL INFORMATION AND PUBLICATION. 11.1 LICENSOR and LICENSEE each agree that all information contained in documents marked "confidential" or "proprietary" and forwarded to one by the other (i) are to be received in strict confidence, (ii) used only for the purposes of this AGREEMENT, and (iii) not disclosed by the recipient party (except as required by law or court order), its agents or employees without the prior written consent of the other party, except to the extent that the recipient party can establish competent written proof that such information:
(a) was in the public domain at the time of disclosure; or
(b) later became part of the public domain through no act or omission of the recipient party, its employees, agents, successors or assigns; or
(c) was lawfully disclosed to the recipient party by a third party having the right to disclose it; or
(d) was already known by the recipient party at the time of disclosure; or
(e) was independently developed by the recipient without use of the other party's confidential information; or
(f) is required by law or regulation to be disclosed.
11.2 Each party's obligation of confidence hereunder will be fulfilled by using at least the same degree of care with the other party's confidential information as it uses to protect its own confidential information, but always at least a reasonable degree of care. This obligation will exist while this AGREEMENT is in force and for a period of three years thereafter.
11.3 LICENSOR reserves the right to publish the general scientific findings from research related to LICENSED SUBJECT MATTER, with due regard to the protection of LICENSEE's confidential information. LICENSOR will submit the manuscript of any proposed publication to LICENSEE at least thirty (30) days before publication, and LICENSEE shall have the right to review and comment upon the publication in order to protect LICENSEE's confidential information. Upon LICENSEE's request, publication may be delayed up to sixty (60) additional days to enable LICENSEE to secure adequate intellectual property protection of LICENSEE's confidential information that would otherwise be affected by the publication.
11.4 The foregoing provisions of this Article XI shall be subject to any rights of, or obligations imposed by any U.S. government agency.
CONFIDENTIAL INFORMATION AND PUBLICATION. 13.1 BOARD and IMMUNICON each agree that all information contained in documents marked "confidential" and forwarded to one by the other (i) are to be received in strict confidence, (ii) used only for the purposes of this AGREEMENT, and (iii) not disclosed by the recipient party, its agents or employees without the prior written consent of the other party, except to the extent that the recipient party can establish competent written proof that such information:
(a) was in the public domain at the time of disclosure;
(b) later became part of the public domain through no act or omission of the recipient party, it's employees, agents, successors or assigns;
(c) was lawfully disclosed to the recipient party by a third party having the right to disclose it;
(d) was already known by the recipient party at the time of disclosure;
(e) was independently developed by the recipient; or
(f) is required by law or regulation to be disclosed.
13.2 Each party's obligation of confidence hereunder shall be fulfilled by using at least the same degree of care with the other party's confidential information as it uses to protect its own confidential information. This obligation shall exist while this AGREEMENT is in force and for a period of 3 years thereafter.
CONFIDENTIAL INFORMATION AND PUBLICATION. XXXXXXXX and LICENSEE each agree that all information contained in documents marked “confidential” and forwarded to one by the other (i) are to be received in strict confidence, (ii) are to be used only for the purposes of this AGREEMENT, and (iii) will not be disclosed by the recipient party (except as required by law or court order), nor by the recipient party’s agents or employees without the prior written consent of the disclosing party, except to the extent that the recipient party can establish by competent written proof that such information:
CONFIDENTIAL INFORMATION AND PUBLICATION. 13.1 Board and PLx each agree that all information contained in documents marked “confidential” and forwarded to one by the other (i) are to be received in strict confidence, (ii) used only for the purposes of this Agreement, and (iii) not disclosed by the recipient party, its agents or employees without the prior written consent of the other party, except to the extent that the recipient party can establish competent written proof that such information:
a. was in the public domain at the time of disclosure;
b. later became part of the public domain through no act or omission of the recipient party, it’s employees, agents, successors or assigns;
c. was lawfully disclosed to the recipient party by a third party having the right to disclose it;
d. was already known by the recipient party at the time of disclosure;
e. was independently developed by the recipient, as evidenced by written documentation; or
f. is required by law or regulation to be disclosed
13.2 Each party’s obligation of confidence hereunder shall be fulfilled by using at least the same degree of care with the other party’s confidential information as it uses to protect its own confidential information. This obligation shall exist while this Agreement is in effect and for a period of three (3) years thereafter.
13.3 UTHSC-H will submit its manuscript for any proposed publication of research related to Licensed Subject Matter to PLx at least thirty (30) days before publication, and PLx shall have up to thirty (30) days to review and comment upon the publication in order to protect PLx’s confidential information. Upon PLx’ request, publication will be delayed for up to sixty (60) days to enable PLx to secure adequate intellectual property protection of PLx’s property that would be adversely affected by the publication.
CONFIDENTIAL INFORMATION AND PUBLICATION. 10.1 Board and Licensee each agree that all information contained in documents marked "confidential" and forwarded to one by the other (i) be received in strict confidence, (ii) be used only for the purposes of this Agreement, and (iii) not be disclosed by the recipient party, its agents or employees without the prior written consent of the other party, except to the extent that the recipient party can establish competent written proof that such information: was in the public domain at the time of disclosure; later became part of the public domain through no act or omission of the recipient party, it’s employees, agents, successors or assigns; was lawfully disclosed to the recipient party by a third party having the right to disclose it; was already known by the recipient party at the time of disclosure; was independently developed by the recipient; or is required by law or regulation to be disclosed.
10.2 Each party’s obligation of confidence hereunder shall be fulfilled by using at least the same degree of care with the other party’s confidential information as it uses to protect its own confidential information. This obligation shall exist while this Agreement is in force and for a period of 3 years thereafter.
10.3 University will submit its manuscript for any proposed publication of research related to Licensed Subject Matter to Licensee at least 30 days before publication, and Licensee shall have the right to review and comment upon the publication in order to protect Licensee’s confidential information. Upon Licensee’s request, publication will be delayed up to 60 additional days to enable Licensee to secure adequate intellectual property protection of Licensee’s property that would be affected by the publication.
CONFIDENTIAL INFORMATION AND PUBLICATION. 14 XII. ASSIGNMENT..................................................................... 15 XIII.
CONFIDENTIAL INFORMATION AND PUBLICATION. In addition, the Confidential Information referred to in Section 7 (a)(iii) above may be disclosed in connection with publications for its own internal research and educational purposes strictly subject to Sections 8 and 9 below and the other provisions of this Agreement. Such disclosure shall not contain any Confidential Information other than that referred to in Section 7 (a)(iii) above. (c)
CONFIDENTIAL INFORMATION AND PUBLICATION. In addition, the Confidential Information referred to in Section 7 (a)(iii) above may be disclosed in connection with publications for its own internal research and educational purposes strictly subject to Sections 8 and 9 below and the other provisions of this Agreement. Such disclosure shall not contain any Confidential Information other than that referred to in Section 7 (a)(iii) above.
(d) Důvěrné informace a nezávislé etické komise. Zdravotnické zařízení a Zkoušející vynaloží veškeré úsilí, aby zajistili souhlas členů Etické Komise s tím, že budou vázáni týmiž závazky mlčenlivosti, jaké se vztahují na Zdravotnické zařízení a Zkoušejícího dle této smlouvy.
CONFIDENTIAL INFORMATION AND PUBLICATION. The parties will treat all Confidential Information as confidential and shall not without the prior written consent of the disclosing party, publish or permit the same to be disclosed to any third party, except Confidential Information disclosed by the Student to UWA for the purpose of being assessed for the Course (but only to the extent necessary for such assessment).
CONFIDENTIAL INFORMATION AND PUBLICATION. 11.1 MDA and LICENSEE each agree that all information contained in documents marked "confidential" and forwarded to one by the other (i) are to be received in strict confidence, (ii) used only for the purposes of this AGREEMENT, and (iii) not disclosed by the recipient party (except as required by law or court order), its agents or employees without the prior written consent of the other party, except to the extent that the recipient party can establish competent written proof that such information: (a) was in the public domain at the time of disclosure; or (b) later became part of the public domain through no act or omission of the recipient party, its employees, agents, successors or assigns; or (c) was lawfully disclosed to the recipient party by a third party having the right to disclose it; or (d) was already known by the recipient party at the time of disclosure; or (e) was independently developed by the recipient without use of the other party's confidential information; or (f) is required by law or regulation to be disclosed.
